Contec Medical Systems Co.,Ltd

SZSE:300869.SZ

20.36 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q22018 Q12017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 110.88299.175127.797122.748125.779368.7249.931130.053148.891183.239189.413204.402254.888260.009290.077360.058581.564169.525140.648102.48372.05872.05886.87386.873135.75378.8290.566116.7990.814138.51356.54856.7956.79
Cost of Revenue 59.85550.19261.6766.459.539132.298124.25467.08282.669100.017101.467108.138128.848124.301165.366157.08204.31958.26172.37658.31237.42237.42247.4947.4964.72945.78542.25762.78443.32969.37626.44427.89427.894
Gross Profit 51.02748.98366.12656.34866.24236.402125.67762.97166.22283.22287.94696.264126.041135.708124.712202.978377.246111.26568.27244.17134.63634.63639.38339.38371.02533.03548.3154.00647.48569.13730.10428.89628.896
Gross Profit Ratio 0.460.4940.5170.4590.5270.6410.5030.4840.4450.4540.4640.4710.4940.5220.430.5640.6490.6560.4850.4310.4810.4810.4530.4530.5230.4190.5330.4620.5230.4990.5320.5090.509
Reseach & Development Expenses 27.43527.1429.33228.30826.49325.00527.18124.79821.81819.45620.84216.29614.8914.03215.87410.71410.96311.18510.99310.7259.4259.4258.6128.6120018.9189.4590013.7656.8836.883
General & Administrative Expenses -5.75710.797-16.15722.611-4.63814.422-6.73215.745-3.2047.667-13.46920.271-5.2167.772-11.79810.579-2.6478.918-27.2215.6645.7055.70516.12316.12314.5713.71615.49715.17214.26711.51517.93611.64211.642
Selling & Marketing Expenses 20.25616.17438.59517.59427.17134.3353.2612.15215.2129.58926.42412.06515.84911.7730.92914.50631.36214.36414.26812.05613.08113.08111.82111.8219.69516.77810.44810.35310.02913.24211.4017.4777.477
SG&A 26.43126.9745.60740.20622.53448.75146.52827.89712.00817.25512.95532.33610.63319.545-10.86925.08528.71623.282-12.95317.71918.61418.61429.74229.74224.26530.49423.64526.67524.29624.75729.33819.11919.119
Other Expenses -2.9390.312-30.6170.197-0.101-0.270.0870.2-0.133-0.036-0.0250.1212.614-0.4620.1610.8880.02-0.235-12.647-0.1360000000000000
Operating Expenses 56.80555.472105.55653.67253.01865.67994.76344.73241.37534.67156.51331.91535.13331.27423.0624.64330.85835.31931.63726.13826.4926.4927.78227.78221.6822.41715.82623.00418.27919.69325.20215.57915.579
Operating Income -5.7782.808-39.439.68922.445188.20523.665.92948.17781.5773.39197.789103.946130.619110.984174.878349.66779.10837.37223.1436.2556.25510.04510.04544.9540.24124.75925.80622.2543.0910.8798.788.78
Operating Income Ratio -0.0520.028-0.3090.0790.1780.510.0940.5070.3240.4450.3870.4780.4080.5020.3830.4860.6010.4670.2660.2260.0870.0870.1160.1160.3310.0030.2730.2210.2450.3110.0160.1550.155
Total Other Income Expenses Net 11.1630.3125.390.197-0.101-0.270.0870.2-0.133-0.036-0.0250.1212.614-0.4620.1610.8880.02-0.2350.598-0.1364.2094.2093.6493.6494.5239.0749.0675.2736.9564.2047.1834.5384.538
Income Before Tax 5.3853.119-34.049.88722.344187.93523.68766.12948.04481.53473.36697.91106.56130.157111.145175.766349.68778.87337.97123.00710.46410.46413.69413.69449.4789.31533.82631.0829.20647.2958.06213.31913.319
Income Before Tax Ratio 0.0490.031-0.2660.0810.1780.510.0950.5080.3230.4450.3870.4790.4180.5010.3830.4880.6010.4650.270.2240.1450.1450.1580.1580.3640.1180.3730.2660.3220.3410.1430.2350.235
Income Tax Expense 1.57-1.233-4.689-2.3449.5117.8831.6917.2995.9768.2269.08612.30418.90615.34312.69324.55954.32810.4963.532.610.9920.9921.8961.8966.6542.7183.9853.6984.7985.4161.5211.4531.453
Net Income 3.8154.352-29.35212.23112.834170.05221.99658.8342.06873.30864.2885.60687.654114.81398.452151.207295.3668.37834.4420.3979.4729.47211.79811.79842.8246.59829.84127.38224.40841.8796.54111.86511.865
Net Income Ratio 0.0340.044-0.230.10.1020.4610.0880.4520.2830.40.3390.4190.3440.4420.3390.420.5080.4030.2450.1990.1310.1310.1360.1360.3150.0840.3290.2340.2690.3020.1160.2090.209
EPS 0.010.011-0.0730.030.0320.420.0550.150.10.180.160.210.220.290.250.40.820.190.0860.060.0250.0250.0350.0350.120.0180.0860.0790.0710.120.0190.0360.036
EPS Diluted 0.010.011-0.0730.0070.0320.420.0460.150.10.180.160.210.220.290.250.40.820.190.0860.060.0250.0250.0350.0350.120.0180.0860.0790.0710.120.0190.0360.036
EBITDA 1.234-3.163-32.526-44.35389.344196.375110.259-45.40785.35149.78682.62599.041134.737105.569110.773179.315356.25176.39538.36725.0239.7269.72613.69513.69548.6373.92427.4128.45825.5646.4024.42412.32512.325
EBITDA Ratio 0.011-0.032-0.255-0.3610.710.5330.441-0.3490.5730.2720.4360.4850.5290.4060.3820.4980.6130.4510.2730.2440.1350.1350.1580.1580.3580.050.3030.2440.2810.3350.0780.2170.217